{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0008-0423#drug","name":"North American Coral Snake Antivenin (Equine)","alternateName":"Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0008-0423"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA101099"},{"@type":"PropertyValue","propertyID":"UNII","value":"Y605XBM2GL"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d"}],"activeIngredient":"CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA101099","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-0423"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T03:09:44.651Z"}}